Search Results 3521-3530 of 17075 for mesenteric fat and ibd
-
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...
-
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...
-
Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...
-
Hematology — Learn about innovative diagnosis and treatment options for blood diseases, including cancers, at Mayo Clinic.
-
The purpose of this study is to compare the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden.
-
There's still time ... Hurry! Your gift now goes 2× as far to help more patients. Double My Impact.
-
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...
-
This phase III trial compares the effect of high dose chemotherapy and the patients' own (autologous) stem cells to observation only in patients with ...
-
The purpose of this study is to compare the cosmetic outcome of Superomedial and Inferior Pedical Breast Reduction. Dynamic Evaluation Of Spinal Alignment And ...
-
Rochester, Minn. The purpose of this study is to compare the outcomes of patients who had standard laparoscopic port placement compared to non-standard port ...